Pfizer Inc.
Compositions and methods for counteracting Factor Xa inhibition
Last updated:
Abstract:
The disclosure provides compositions and methods for counteracting the effects of direct activated Factor X (FXa) inhibitors in a subject by administering a variant of FXa.
Status:
Grant
Type:
Utility
Filling date:
17 Jan 2018
Issue date:
17 Mar 2020